Market scenario:
Injectable
drug delivery devices are the devices used to administer drugs into the
circulatory system. It is the most effective and common route for the
administration of most therapeutic agents to ensure a quick response.
Injectable drugs are used when patient is unconscious and require quick effect.
These devices are majorly used during treatment of diseases like cancer and
diabetes. According to WHO in 2012, 14.1 million cancer cases around the world
were registered out of which 6.7 million were women and 7.4 million were men.
This number is expected to increase to 24 million by 2035. Increasing cancer
population is the major factor for the growth of the market. Global injectable
drug delivery devices market is driven by rising prevalence of chronic
diseases, increasing occurrence of needle-stick injuries, increasing use of
biologics. Technological advancements, improving patient compliance, beneficial
reimbursement policies, increasing healthcare awareness and increasing
geriatric population has also contributed to the growth of the market. Whereas,
risk of blood-borne infections, safety concerns regarding the use of
injectable, introduction of the alternative drug delivery devices would
restrain the growth of the market.
Global
injectable drug delivery devices market is expected to grow at a CAGR of 11.8%
during forecasted period.
Study
objectives global injectable drug delivery devices market
- To
provide the detail information about drivers and factors restraining the
market growth.
- To
provide the market growth map over the forecasted period 2017-2023
- To
provide detailed analysis of the market structure along with forecast for
the next 7 years of various segments and sub-segments of the global
injectable drug delivery devices
- To
provide the graphs and analyze the market on various factors like- Price
Analysis, Supply Chain Analysis, Porters Five Force Analysis etc.
- To
provide the trends and opportunities in global injectable drug delivery
devices
- To
provide historical and forecast revenue of the market segments and
sub-segments with respect to the main geographies.
- To
provide the overview of key players and their strategic profiles in the
market and drawing a competitive landscape for the market
Key
players for global injectable drug delivery devices market
Becton,
Dickinson and Company (US), Baxter International (US), Schott AG (Germany), Eli
Lilly and Company (US), Pfizer (US), Gerresheimer AG (Germany), Terumo
Corporation (Japan), Antares Pharma, Inc. (US), Novo Nordik (Denmark), Sanofi
SA (France), Unilife Corporation (US), Zogenix, Inc (US), Hospira, Inc (US),
Presage Bioscience (US), MicroCHIPS, Inc (US), Pearl Therapeutics Inc (US),
Genentech Inc. (US), Bend Research (US).
Segmentation
Global
injectable drug delivery devices market is segmented on the basis of type into
devices and formulation. Devices are further segmented into self-injection
devices and conventional injection devices. By formulation, they are sub
segmented into conventional drug delivery, novel drug delivery and others. On
the basis of application, the market is segmented into immune disorder, cancer,
diabetes, and other. And on the basis of end users the market is segmented into
hospitals, homecare, clinics, and other.
Regional
analysis
Global
injectable drug delivery devices market is dominated by America owning to
increasing patient population suffering from diabetes and cancer. Increasing
aging population and technological development is also supporting the growth of
the market. Europe accounts second largest market for injectable drug delivery
devices which is followed by Asia Pacific. Huge patient population and rapid
development of economies in countries of Asia Pacific is the major driver for
the market in this region.
Browse Complete 80 Pages Premium Research Report
Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/injectable-drug-delivery-devices-market-1211
Detailed Table Of Contents:
1. Introduction
1.1
Definition
1.2
Scope Of Study
1.2.1
Research Objective
1.2.2
Assumptions & Limitations
1.2.2.1
Assumptions
1.2.2.2
Limitations
1.3
Market Structure:
2. Research Methodology
2.1
Research Process:
2.2
Primary Research
2.3
Secondary Research:
3. Market Dynamics
3.1
Drivers
3.2
Restraints
3.3
Opportunities
3.4
Macroeconomic Indicators
...Continued
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment